Navigation Links
Study Says Chest Pain Toll in Women is More than Physical

Considering both direct and indirect costs, the financial burden on a woman who has chest pain and blocked coronary arteries may total more than $1 million during her lifetime// . But even a woman who suffers from angina without an obstruction can expect her condition to take a toll in the neighborhood of $800,000, according to a report.

C. Noel Bairey Merz, M.D., medical director of the Preventive and Rehabilitative Cardiac Center at Cedars-Sinai Medical Center, medical director of Women’s Health, and one of the article’s authors, said researchers looked at the cases of 883 women over five years in reaching their conclusions.

'Total cumulative costs were higher for women who have two or three blocked vessels, due largely to the number of outpatient visits and procedures performed. But women with nonobstructive coronary artery disease (CAD) or one blocked artery had proportionately higher drug costs, which resulted in higher indirect costs,' said Bairey Merz, chair of the Women’s Ischemia Syndrome Evaluation (WISE), from which the estimates were derived.

WISE is a multi-center study launched in 1996 that is funded by the National Heart, Lung and Blood Institute of the National Institutes of Health. This research also was supported by a grant from the National Center for Research Resources.

The research team totaled direct costs from cardiovascular hospitalizations, coronary interventions, outpatient testing, and visits to health care professionals. Indirect costs included such factors as hours lost from work for health care, estimated reduced productivity hours, transportation charges, and the costs of drugs and medical devices.

For women with obstructive CAD, average lifetime costs were estimated to be more than $1 million. But even for those with nonobstructive CAD the average was $767,288 – and this is a group that has been left out of earlier estimates of the economic burden of heart disease; most studi es have focused almost exclusively on men.

'If we had an adequate understanding of the different causes of chest pain in women, we wouldn’t be spending all this money on women who have open arteries but keep cycling through the system. This is not a small problem, and it is not going to go away, which means we must continue to invest in research specific to women,' Bairey Merz said.

Among women in the study, those with vessel obstructions tended to be older and postmenopausal with a greater prevalence of cardiac risk factors. Those with nonobstructive disease were more often obese and with prior hysterectomy, polycystic ovary syndrome and a positive stress test. When the researchers extrapolated lifetime costs from the five-year data, they took age into consideration. For example, for younger women, total cost was related to greater life expectancy and drug treatment costs.

In a study published earlier this year, the WISE researchers shed light on a female-specific vascular disorder that often causes women to suffer from heart-related chest pain even though their arteries are not blocked by plaque deposits. Two areas of dysfunction – one in the cells lining coronary arteries and another in the tiny vessels branching within the heart itself – combine to deprive the heart muscle of oxygen. These functional rather than structural abnormalities, while not seen on coronary angiography, result in abnormal resistance that limits blood flow to the heart tissue.

'Nearly half of women undergoing clinically indicated coronary angiography have nonobstructive CAD. Now we are beginning to appreciate the financial burden that is placed upon these women – as well as on the health care system – as they continue to seek medications and therapies to reduce ischemia and angina over their lifetimes,' said Bairey Merz, who holds the Women’s Guild Chair in Women’s Health at Cedars-Sinai.

Compared with women who have blocked arte ries, women with nonobstructive CAD are at lower risk for cardiovascular death, but their ongoing symptoms and therapeutic interventions affect their general well-being and quality of life. Moreover, according to the study, one woman in five with nonobstructive CAD required hospitalization at some point during the five-year follow-up period, and 46 percent of those with nonobstructive CAD had typical angina at five years, a rate similar to that of women with blocked arteries.

Source-Newswse
SRM
'"/>




Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 13, 2017 , ... “The Journey: From the Mountains to the Mission Field”: ... souls in the Philippines. “The Journey: From the Mountains to the Mission Field” is ... Bible. She has taught all ages and currently teaches a class of ladies at ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Leading pediatric oncology ... in Washington, D.C., for the 49th Congress of the International Society of Paediatric ... President of the Center for Cancer and Blood Disorders at Children’s National, ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
Breaking Medicine Technology: